Principal Investigator:
Mohammed Fouda, Fellow in Neurological Surgery
Background & Unmet Need
- Craniosynostosis is a condition characterized by premature fusion of cranial sutures that affects ~ 1 in every 2,500 live births globally
- If left untreated, craniosynostosis can lead to disrupted skull growth, elevated intracranial pressure and serious neurodevelopmental abnormalities
- Craniofacial distraction osteogenesis (DO) enables gradual distraction and controlled bone regeneration for patients with abnormal craniofacial morphology
- However, conventional craniofacial DO systems require external activation ports that increase the risk of wound infection, mechanical failure, and premature removal of the distraction system.
- Additionally, manual external actuation introduces user-dependent variability and mechanical inconsistency
- Unmet Need: Craniofacial DO systems with reduced risk of infection and more precise control of the distraction mechanism
Technology Overview
- The Technology: A magnet-actuated craniofacial (MAC) distraction system for contactless, noninvasive delivery of the mechanical forces required for craniofacial DO
- The MAC system exploits magnetic coupling between external and internal magnets to generate noninvasive, controlled mechanical forces without direct physical contact with the external environment
- Three-dimensional magnetostatic finite element modeling (FEM) demonstrated the feasibility of achieving clinically relevant transmissible torque using magnetic actuation
- PoC Data: In a cadaveric feasibility study, the MAC system exhibited reliable mechanical performance, positional stability, and resistance to back-drivability under anatomically relevant conditions
Technology Applications
- Treatment of complex craniosynostosis, including syndromic, multi-suture craniosynostosis
- Treatment of other craniofacial abnormalities such as mandibular micrognathia and midface hypoplasia
Technology Advantages
- Potential to reduce the risk of infection and mechanical failure
- Magnetic coupling enables predictable, adaptable, and patient-specific control of distraction kinetics

Resources
Intellectual Property
Patents
- US Applications Filed
Cornell Reference
- 10735
Contact Information
For additional information please contact
Donna Rounds
Associate Director, Business Development and Licensing
Phone: (646) 780-8775
Email: djr296@cornell.edu
